SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001171843-22-003457
Filing Date
2022-05-09
Accepted
2022-05-09 16:00:33
Documents
14

Document Format Files

Seq Description Document Type Size
1 DEFA14A defa14a_050922.htm DEFA14A 25412
2 GRAPHIC logo.jpg GRAPHIC 3552
3 GRAPHIC defa14a_01.jpg GRAPHIC 165321
4 GRAPHIC defa14a_02.jpg GRAPHIC 136693
5 GRAPHIC defa14a_03.jpg GRAPHIC 225652
6 GRAPHIC defa14a_04.jpg GRAPHIC 179668
7 GRAPHIC defa14a_05.jpg GRAPHIC 192296
8 GRAPHIC defa14a_06.jpg GRAPHIC 185789
9 GRAPHIC defa14a_07.jpg GRAPHIC 146339
10 GRAPHIC defa14a_08.jpg GRAPHIC 189337
11 GRAPHIC defa14a_09.jpg GRAPHIC 253880
12 GRAPHIC defa14a_10.jpg GRAPHIC 225527
13 GRAPHIC defa14a_11.jpg GRAPHIC 207842
14 GRAPHIC defa14a_12.jpg GRAPHIC 151291
  Complete submission text file 0001171843-22-003457.txt   3143050
Mailing Address 32 WIGGINS AVENUE BEDFORD MA 01730
Business Address 32 WIGGINS AVENUE BEDFORD MA 01730 (781) 457-9000
Anika Therapeutics, Inc. (Filer) CIK: 0000898437 (see all company filings)

IRS No.: 043145961 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-14027 | Film No.: 22904764
SIC: 3841 Surgical & Medical Instruments & Apparatus